Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 1417408, 8 pages
http://dx.doi.org/10.1155/2016/1417408
Clinical Study

Screening of Undiagnosed Hypothyroidism in Elderly Persons with Diabetes according to Age-Specific Reference Intervals for Serum Thyroid Stimulating Hormone and the Impact of Antidiabetes Drugs

1Hospital Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, 20241260 Rio de Janeiro, RJ, Brazil
2Diagnosticos da America SA, Rio de Janeiro, RJ, Brazil

Received 12 February 2016; Revised 5 May 2016; Accepted 23 May 2016

Academic Editor: Dario Iafusco

Copyright © 2016 Rosita Fontes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. P. Joslin, H. F. Root, P. White, and A. Marble, Treatment of Diabetes Mellitus, Henry Kimpton, London, UK, 10th edition, 1959.
  2. R. Kadiyala, R. Peter, and O. E. Okosieme, “Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies,” International Journal of Clinical Practice, vol. 64, no. 8, pp. 1130–1139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. J. Díez, P. Sánchez, and P. Iglesias, “Prevalence of thyroid dysfunction in patients with type 2 diabetes,” Experimental and Clinical Endocrinology and Diabetes, vol. 119, no. 4, pp. 201–207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Vaidya, “Association of thyroid dysfunction and diabetes mellitus: is the co-existence incidental?” Journal of Obesity and Metabolic Research, vol. 1, no. 2, pp. 83–84, 2014. View at Publisher · View at Google Scholar
  5. P. Perros, R. J. McCrimmon, G. Shaw, and B. M. Frier, “Frequency of thyroid dysfunction in diabetic patients: value of annual screening,” Diabetic Medicine, vol. 12, no. 7, pp. 622–627, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. A. D. C. Riquetto, R. M. de Noronha, E. M. Matsuo et al., “Thyroid function and autoimmunity in children and adolescents with Type 1 Diabetes Mellitus,” Diabetes Research and Clinical Practice, vol. 110, no. 1, pp. e9–e11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. D. H. Akbar, M. M. Ahmed, and J. Al-Mughales, “Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics,” Acta Diabetologica, vol. 43, no. 1, pp. 14–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. American Diabetes Association, “Executive summary: standards of medical care in diabetes–2014,” Diabetes Care, vol. 37, pp. S5–S13, 2014. View at Google Scholar · View at Scopus
  9. J. R. Garber, R. H. Cobin, H. Gharib et al., “Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association,” Thyroid, vol. 22, no. 12, pp. 1200–1235, 2012. View at Publisher · View at Google Scholar
  10. C. C. Palma, M. Pavesi, V. Nogueira et al., “Prevalence of thyroid dysfunction in patients with diabetes mellitus,” Diabetology & Metabolic Syndrome, vol. 5, no. 1, pp. 58–62, 2013. View at Publisher · View at Google Scholar
  11. A. Papazafiropoulou, A. Sotiropoulos, A. Kokolaki, M. Kardara, P. Stamataki, and S. Pappas, “Prevalence of thyroid dysfunction among Greek type 2 diabetic patients attending an outpatient clinic,” Journal of Clinical Medicine Research, vol. 2, no. 2, pp. 75–78, 2010. View at Publisher · View at Google Scholar
  12. L. Demitrost and S. Ranabir, “Thyroid dysfunction in type 2 diabetes mellitus: a retrospective study,” Indian Journal of Endocrinology and Metabolism, vol. 16, pp. S334–S335, 2012. View at Google Scholar
  13. Y. Aoki, R. M. Belin, R. Clickner, R. Jeffries, L. Phillips, and K. R. Mahaffey, “Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002),” Thyroid, vol. 17, no. 12, pp. 1211–1223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Yoshihara, J. Y. Noh, H. Ohye et al., “Reference limits for serum thyrotropin in a Japanese population,” Endocrine Journal, vol. 58, no. 7, pp. 585–588, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. I. Surks and J. G. Hollowell, “Age-specific distribution of serum thyrotropin and antithyroid antibodies in the U.S. population: implications for the prevalence of subclinical hypothyroidism,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 12, pp. 4575–4582, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Boucai and M. I. Surks, “Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice,” Clinical Endocrinology, vol. 70, no. 5, pp. 788–793, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Jonklaas, A. C. Bianco, A. J. Bauer et al., “Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement,” Thyroid, vol. 24, no. 12, pp. 1670–1751, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Hershman and K. Konerding, “Effects of sulfonylurea drugs on the thyroid and serum protein binding of thyroxine in the rat,” Endocrinology, vol. 83, no. 1, pp. 74–78, 1968. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Pappa and M. Alevizaki, “Metformin and thyroid: an update,” European Thyroid Journal, vol. 2, pp. 22–28, 2013. View at Google Scholar
  20. C. Cappelli, M. Rotondi, I. Pirola et al., “TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients,” Diabetes Care, vol. 32, no. 9, pp. 1589–1590, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. J. Díez and P. Iglesias, “Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes,” Clinical Endocrinology, vol. 78, no. 4, pp. 505–511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. R. B. Hunton, M. V. Wells, and E. W. Skipper, “Hypothyroidism in diabetics treated with sulphonylurea,” The Lancet, vol. 286, no. 7410, pp. 449–451, 1965. View at Publisher · View at Google Scholar · View at Scopus
  23. (Law 1944/53-Law No. 1,944, of August 14, 1953). Published by the Presidency of the Republic, in D.O.I (Official Diary of the Union), 8.20.1953.
  24. L. S. Netto, C. M. Coeli, E. Micmacher et al., “Longitudinal study of pituitary-thyroid axis in pregnancy,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 48, no. 4, pp. 493–498, 2004 (Portuguese). View at Google Scholar · View at Scopus
  25. Agência Nacional de Vigilância Sanitária, Resultado do Monitoramento do Teor de Iodo no Sal, 2011, December 2015, http://portal.anvisa.gov.br/documents/33916/395584/Relat%25C3%25B3rio%2BPro.Iodo%2B2011.pdf/38e0e2be-d2a6-48ca-b6cf-abdba23f2a1d.
  26. R. Fontes, C. R. Coeli, F. Aguiar, and M. Vaisman, “Reference interval of thyroid stimulating hormone and free thyroxine in a reference population over 60 years old and in very old subjects (over 80 years): comparison to young subjects,” Thyroid Research, vol. 6, no. 1, pp. 13–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 35, supplement 1, pp. S64–S71, 2012. View at Publisher · View at Google Scholar
  28. J. G. Hollowell, N. W. Staehling, W. Dana Flanders et al., “Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III),” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 2, pp. 489–499, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. American Diabetes Association, “Executive summary: standards of medical care in diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S4–S10, 2012. View at Google Scholar
  30. R. A. Vigersky, A. Filmore-Nassar, and A. R. Glass, “Thyrotropin suppression by metformin,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 1, pp. 225–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Cappelli, M. Rotondi, I. Pirola et al., “Thyreotropin levels in diabetic patients on metformin treatment,” European Journal of Endocrinology, vol. 167, no. 2, pp. 261–265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-P. Fournier, H. Yin, O. H. Y. Yu, and L. Azoulay, “Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus,” Canadian Medical Association Journal, vol. 186, no. 15, pp. 1138–1145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Chau-Van, M. Gamba, R. Salvi, R. C. Gaillard, and F. P. Pralong, “Metformin inhibits adenosine 5′-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons,” Endocrinology, vol. 148, no. 2, pp. 507–511, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. H.-J. Kim, E.-Y. Park, M.-J. Oh et al., “Central administration of metformin into the third ventricle of C57BL/6 mice decreases meal size and number and activates hypothalamic S6 kinase,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 305, no. 5, pp. R499–R505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. M. López, L. Varela, M. J. Vázquez et al., “Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance,” Nature Medicine, vol. 16, no. 9, pp. 1001–1008, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Krysiak and B. Okopien, “The effect of metformin on the hypothalamic-pituitary-thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism,” Journal of Clinical Pharmacology, vol. 55, no. 1, pp. 45–49, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. E. A. Nikkilä, T. Jakobson, S. G. Jokipii, and K. Karlsson, “Thyroid function in diabetic patients under long-term sulfonylurea treatment,” Acta Endocrinologica, vol. 33, pp. 623–629, 1960. View at Google Scholar · View at Scopus
  38. M. L. England, J. M. Hartnell, J. M. Hersham, and S. R. Levin, “Glyburide does not alter thyroid function,” Diabetes Research, vol. 3, no. 9, pp. 471–474, 1986. View at Google Scholar · View at Scopus
  39. S. M. Ferrari, P. Fallahi, R. Vita, A. Antonelli, and S. Benvenga, “Peroxisome proliferator-activated receptor-γ in thyroid autoimmunity,” PPAR Research, vol. 2015, Article ID 232818, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Nyrnes, R. Jorde, and J. Sundsfjord, “Serum TSH is positively associated with BMI,” International Journal of Obesity, vol. 30, no. 1, pp. 100–105, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. De Moura Souza and R. Sichieri, “Association between serum TSH concentration within the normal range and adiposity,” European Journal of Endocrinology, vol. 165, no. 1, pp. 11–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Petrosyan, “Relationship between high normal TSH levels and metabolic syndrome components in type 2 diabetic subjects with euthyroidism,” Journal of Clinical and Translational Endocrinology, vol. 2, no. 3, pp. 110–113, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Marzullo, A. Minocci, M. A. Tagliaferri et al., “Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 8, pp. 3965–3972, 2010. View at Publisher · View at Google Scholar · View at Scopus